Archive for September 2023
Massachusetts’ biopharma industry keeps growing. Two headwinds could slow it.
Massachusetts’ life sciences industry grew by more than 7,000 jobs last year, outpacing competitor states even as the so-called "Covid boom" began to wane. Read More
Read More‘A little bit surprising:’ Analysts react to Toast CEO transition
Analysts are wondering about the incoming chief executive’s lack of experience when running a public company. Still, they believe the restaurant-technology provider will be "in good hands." Read More
Read MoreBerkshire Bank launches cannabis banking program
The new program is part of the bank’s “inclusive banking programs,” and is designed for all cannabis-related, plant-touching businesses, many of which have struggled with access to financial services. Read More
Read MoreHack.Diversity’s new CEO is former Topeka mayor, Harvard grad
Hack.Diversity has undergone major changes over the last two years, including spinning out into a nonprofit from the New England Venture Capital organization, expanding into NYC and now naming a new CEO. Read More
Read MoreLocal REITs call off merger in face of fierce investor resistance
Shareholders mounted a public campaign against the deal, questioning the merger’s value as well as perceived conflicts of interests at The RMR Group, the manager of both real estate investment trusts. Read More
Read MoreDPH rejects Leominster Hospital plan to close maternity unit after push from community advocates
The UMass Memorial Health hospital based in Leominster was slated to close on Sept. 23, but after DPH rejected their plans, the hospital has to answer more questions about how it will maintain birthing services for the community. Read More
Read MoreBoston-based Crestwood Advisors Group merges with R.I. wealth management firm
Boston-based investment advisory and wealth management firm Crestwood Advisors Group, LLC, has completed its merger with Providence-based Endurance Wealth Management, Inc. Read More
Read MoreThree execs leave Infinity Pharmaceuticals after failed merger, layoffs
Cambridge biotech Infinity Pharmaceuticals is clearing out its C-suite in the wake of a failed merger agreement that had already cost 21 jobs. Read More
Read MoreBostInno Approved: Here are the September events you need to know about
This month’s featured events include Boston TechJam, Startup Boston Week, Techstars Startup Weekend and more. Read More
Read MoreThe New England Patriots are the second-most valuable team in the NFL
The Patriots may struggle to reach what used to be their perennial perch at or near the top of the NFL standings this season. Their valuation, on the other hand, is higher than ever. Read More
Read More